Search Results - "竹村, 周平"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    B型ウイルス肝炎に対するインターフェロンの治療効果(第1報)インターフェロンの少量投与による検討 by 松村, 直幸, 吉川, 敏一, 古川, 泰正, 渡辺, 幸市, 竹村, 周平, 福本, 圭志, 近藤, 元治, 吉川, 正哉, 川上, 広育, 岸田, 綱太郎

    Published in 日本内科学会雑誌 (10-09-1981)
    “…B型ウイルス肝炎におけるヒト白血球インターフェロン(HLIF)の治療効果を,今回は少量投与法を用いて検討した. 1) HBsAg抗原陽性肝疾患患者12例およびHBウイルス健康保有者1例に, HLIF5×104単位の1回筋注投与を行ない,経時的にHBsAg抗原量の変動を観察した結果,…”
    Get full text
    Journal Article
  6. 6

    Kinetics of immune complex deposition and influence of decomplementation on their clearance in cationized antigen induced acute serum sickness by FUKUDA, WATARU, TAKEMURA, SHUHEI, YANAGIDA, KUNIO, KASAMATSU, YOSHIHIRO, DOI, TAKASHI, OKAMOTO, MASAYUKI, ONODERA, HIDEKI, DEGUCHI, MASAKO, VEDA, MASAHIRO, SUGINO, SHIGERU, KONDO, MOTOHARU

    Published in Nihon Jinzo Gakkai shi (01-03-1991)
    “…Using a murine acute serum sickness model caused by cationized bovine γ-globulin (CBGG), the histological findings, accumulation of CBGG in the organs and the…”
    Get full text
    Journal Article
  7. 7

    Imipenemによる補体殺菌能増強作用 by 福田, 亙, 竹村, 周平, 柳田, 国雄, 岡本, 雅之, 笠松, 美宏, 小野寺, 秀記, 出口, 雅子, 上田, 正博, 杉野, 成, 近藤, 元治

    Published in CHEMOTHERAPY (1990)
    “…Imipenem (IPM) の細菌に対する血清・補体との協力的殺菌作用について, 検討を加えた。1/4の最小発育阻止濃度 (MIC) のIPMと1/2増殖阻止濃度の正常ヒト血清を共存させると, グラム陰性菌であるEscherichia coli (E.coli), Pseudomonas…”
    Get full text
    Journal Article
  8. 8

    Ceftazidimeと血清・補体との協力的殺菌作用 by 柳田, 国雄, 竹村, 周平, 小野寺, 秀記, 笠松, 美宏, 岡本, 雅之, 福田, 亙, 出口, 雅子, 上田, 正博, 杉野, 成, 近藤, 元治

    Published in CHEMOTHERAPY (1990)
    “…Ceftazidime (CAZ) の細菌に対する血清・補体との協力的殺菌作用について, 補体の面から検討を加えた。 最小発育阻止濃度 (MIC) の1/4濃度のCAZと5%正常ヒト血清 (NHS) を共存させるとグラム陰性菌であるEscherichia coli, Pseudomonas aeruginosa,…”
    Get full text
    Journal Article
  9. 9

    Cefbuperazoneによる補体殺菌能増強作用 by 出口, 雅子, 竹村, 周平, 小野寺, 秀記, 上田, 正博, 杉野, 成, 近藤, 元治

    Published in CHEMOTHERAPY (1987)
    “…Cefbuperazone (CBPZ, トミポラン®) の細菌に対する血清・補体との協力的殺菌作用について, 補体の面から検討を加えた。 1/4の最小発育阻止濃度 (MIC) のCBPZと5%正常ヒト血清 (NHS) を共存させると, グラム陰性菌であるEscherichia coli (E. coli),…”
    Get full text
    Journal Article
  10. 10

    Plasma levels of complement fragments during hemodialysis in patients with chronic renal failure by UEDA, MASAHIRO, DEGUCHI, MASAKO, TAKEMURA, SHUHEI, KASAMATSU, YOSHIHIRO, YANAGIDA, KUNIO, FUKUDA, WATARU, OKAMOTO, MASAYUKI, ONODERA, HIDEKI, SUGINO, SIGERU, KONDO, MOTOHARU, SHIKATA, TSUGUO

    Published in Nihon Jinzo Gakkai shi (1990)
    “…The kinetics of hemodialysis-induced leukopenia and generation of complement frag-ments including C3a, C5a, C4d, iC3b and Bb were investigated in 14 patients…”
    Get full text
    Journal Article
  11. 11

    Changes of Complement in Immune Complex Glomerulonephritis Induced by Cationized Antigen by FUKUDA, WATARU, TAKEMURA, SHUHEI, YANAGIDA, KUNIO, OKAMOTO, MASAYUKI, KASAMATSU, YOSHIHIRO, ONODERA, HIDEKI, DEGUCHI, MASAKO, UEDA, MASAHIRO, SUGINO, SHIGERU, KONDO, MOTOHARU

    Published in Nihon Jinzo Gakkai shi (01-09-1989)
    “…Complement system takes an important role in the pathogenesis of immune complex glomerulonephritis. In this study the precise changes of serum complement and…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    SYNERGETIC BACTERICIDAL EFFECT WITH SERUM COMPLEMENT BY CBPZ by DEGUCHI, MASAKO, TAKEMURA, SHUHEI, ONODERA, HIDEKI, UEDA, MASAHIRO, SUGINO, SHIGERU, KONDO, MOTOHARU

    Published in CHEMOTHERAPY (1987)
    “…The influence of cefbuperazone (CBPZ) on the synergetic bactericidal effect with serum complement was investigated. One-forth of minimal inhibitory…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The relationship between complement C3 receptors (CR1, CR3) on polymorphonuclear leukocytes and complement fragments during hemodialysis by VEDA, MASAHIRO, DEGUCHI, MASAKO, TAKEMURA, SHUHEI, KASAMATSU, YOSHIHIRO, YANAGIDA, KUNIO, FUKUDA, WATARU, OKAMOTO, MASAYUKI, ONODERA, HIDEKI, SUGINO, SIGERU, KONDO, MOTOHARU

    Published in Nihon Jinzo Gakkai shi (1991)
    “…The expression of complement receptor type 1 (CR1) and type 3 (CR3) on polymorphonuclear leukocytes (PMNs) and generation of complement fragments, C3a, C5a,…”
    Get full text
    Journal Article
  18. 18

    Demonstration and characterization of CD46, membrane cofactor protein in the stomach by Seto, N, Takemura, S, Nakanishi, S, Doi, T, Ichio, N, Nakahara, R, Kasamatsu, Y, Yanagida, K, Okamoto, M, Onodera, H, Kondo, M

    “…CD46, membrane cofactor protein, is a glycoprotein widely present on the cell membranes and is different in molecular weight among organs or cells in the same…”
    Get more information
    Journal Article
  19. 19

    A case of secondary myelodysplastic syndrome following chemotherapy for lung cancer by Uemura, M, Kasamatsu, Y, Sawada, M, Takemura, S, Sugino, S, Kondou, M

    Published in Nihon Kyōbu Shikkan Gakkai zasshi (01-10-1992)
    “…A case of secondary myelodysplastic syndrome (MDS) following chemotherapy for lung cancer is reported. A 78-year-old man, with a smoking history of 20…”
    Get more information
    Journal Article
  20. 20

    Expression and characterization of CD46, membrane cofactor protein, in human colonic mucosa by Nakanishi, S, Takemura, S, Seto, N, Yanagida, K, Doi, T, Ichio, N, Nakahara, R, Kasamatsu, Y, Okamoto, M, Onodera, H, Kondo, M

    “…CD 46, membrane cofactor protein (MCP), is a membrane regulatory glycoprotein of the complement system, and acts as a cofactor of factor I, which inactivates…”
    Get more information
    Journal Article